H W Thaler1, C S Sterke, T J M van der Cammen. 1. Tischa J.M. van der Cammen, MD, PhD, FRCP, Associate Professor of Geriatric Medicine, Section of Geriatric Medicine, Department of Internal Medicine, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands, Tel: +31-10-703.59.79; Fax: +31-10-703.47.68, E-mail: t.vandercammen@erasmusmc.nl.
Abstract
OBJECTIVES: To examine the association between Proton pump inhibitors (PPIs) use and falls and fractures. DESIGN: A cross-sectional study. SETTING AND PARTICIPANTS: 400 female patients aged 70 years or older who were consecutively admitted to the Trauma Center Meidling, Vienna, after a fall and who required hospital admission. METHODS: We quantified the strength of the associations between PPI use and falls, and between PPI use and fractures, using a logistic regression. RESULTS: use of PPIs was significantly associated with risk of recurrent falls (OR 1.92, 95% CI = 1.05 - 3.50, p = 0.04) as well as with risk of a fracture (OR 2.15, 95% CI 1.10 - 4.21, p = 0.03). CONCLUSIONS: In conclusion, our results provide further evidence that PPI use may increase risk of falls and fractures in older women and highlight the need for clinicians to reassess the original indication and the need for continuation of PPIs on a regular basis.
OBJECTIVES: To examine the association between Proton pump inhibitors (PPIs) use and falls and fractures. DESIGN: A cross-sectional study. SETTING AND PARTICIPANTS: 400 female patients aged 70 years or older who were consecutively admitted to the Trauma Center Meidling, Vienna, after a fall and who required hospital admission. METHODS: We quantified the strength of the associations between PPI use and falls, and between PPI use and fractures, using a logistic regression. RESULTS: use of PPIs was significantly associated with risk of recurrent falls (OR 1.92, 95% CI = 1.05 - 3.50, p = 0.04) as well as with risk of a fracture (OR 2.15, 95% CI 1.10 - 4.21, p = 0.03). CONCLUSIONS: In conclusion, our results provide further evidence that PPI use may increase risk of falls and fractures in older women and highlight the need for clinicians to reassess the original indication and the need for continuation of PPIs on a regular basis.
Authors: Shelly L Gray; Andrea Z LaCroix; Joseph Larson; John Robbins; Jane A Cauley; JoAnn E Manson; Zhao Chen Journal: Arch Intern Med Date: 2010-05-10
Authors: Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin Journal: JAMA Intern Med Date: 2014-04 Impact factor: 21.873
Authors: Klaas A Hartholt; Esther M M Van Lieshout; Suzanne Polinder; Martien J M Panneman; Tischa J M Van der Cammen; Peter Patka Journal: J Neurotrauma Date: 2011-04-15 Impact factor: 5.269
Authors: Marjan Askari; Saied Eslami; Alice C Scheffer; Stephanie Medlock; Sophia E de Rooij; Nathalie van der Velde; Ameen Abu-Hanna Journal: Drugs Aging Date: 2013-10 Impact factor: 3.923
Authors: John C Woolcott; Kathryn J Richardson; Matthew O Wiens; Bhavini Patel; Judith Marin; Karim M Khan; Carlo A Marra Journal: Arch Intern Med Date: 2009-11-23
Authors: Tamires Terezinha Gallo da Silva; Jarbas Melo Filho; Simone Biesek; Audrin Said Vojciechowski; Victória Zeghbi Cochenski Borba; Anna Raquel Silveira Gomes Journal: Front Public Health Date: 2022-05-17
Authors: Safoura Sheikh Rezaei; Hana Šinkovec; Alexander Schöberl; Christoph Rinner; Georg Heinze; Michael Wolzt; Walter Gall Journal: BMC Geriatr Date: 2021-02-10 Impact factor: 3.921